Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials.

Identifieur interne : 000285 ( Hal/Checkpoint ); précédent : 000284; suivant : 000286

A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials.

Auteurs : Thierry Boge [France] ; Michel Rémigy [France] ; Sarah Vaudaine [France] ; Jérôme Tanguy [France] ; Raphaëlle Bourdet-Sicard [France] ; Sylvie Van Der Werf [France]

Source :

RBID : Hal:pasteur-00457701

Abstract

BACKGROUND: Influenza vaccination is recommended for the elderly in many countries, but immune responses are weaker compared to younger adults. OBJECTIVE: To investigate the impact of daily consumption of a probiotic dairy drink on the immune response to influenza vaccination in an elderly population of healthy volunteers over 70 years of age. DESIGN: Two randomised, multicentre, double-blind, controlled studies were conducted during two vaccination seasons in 2005-2006 (pilot) and 2006-2007 (confirmatory). Eighty-six and 222 elderly volunteers consumed either a fermented dairy drink, containing the probiotic strain Lactobacillus casei DN-114 001 and yoghurt ferments (Actimel, or a non-fermented control dairy product twice daily for a period of 7 weeks (pilot) or 13 weeks (confirmatory). Vaccination occurred after 4 weeks of product consumption. Geometric mean antibody titres (GMT) against the 3 viral strains composing the vaccine (H1N1, H3N2, and B) were measured at several time intervals post-vaccination by haemagglutination inhibition test. RESULTS: In the pilot study, the influenza-specific antibody titres increased after vaccination, being consistently higher in the probiotic product group compared to the control group under product consumption. Similarly, in the confirmatory study, titres against the B strain increased significantly more in the probiotic group than in the control group at 3, 6 and 9 weeks post-vaccination under product consumption (p=0.020). Significant differences in seroconversion between the groups by intended to treat analysis were still found 5 months after vaccination. Similar GMT results were observed for the H3N2 strain and H1N1 strain, confirming the results of the pilot study. CONCLUSION: These studies demonstrate that daily consumption of this particular probiotic product increased relevant specific antibody responses to influenza vaccination in individuals of over 70 years of age and may therefore provide a health benefit in this population.


Url:
DOI: 10.1016/j.vaccine.2009.06.094

Links toward previous steps (curation, corpus...)


Links to Exploration step

Hal:pasteur-00457701

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials.</title>
<author>
<name sortKey="Boge, Thierry" sort="Boge, Thierry" uniqKey="Boge T" first="Thierry" last="Boge">Thierry Boge</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-108489" status="INCOMING">
<orgName>Centre Hospitalier de Bourg en Bresse</orgName>
<desc>
<address>
<addrLine>Avenue Louis Jourdan, 01012 Bourg en Bresse</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-325947" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-325947" type="direct">
<org type="institution" xml:id="struct-325947" status="INCOMING">
<orgName>Centre Hospitalier de Bourg en Bresse</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Remigy, Michel" sort="Remigy, Michel" uniqKey="Remigy M" first="Michel" last="Rémigy">Michel Rémigy</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-108490" status="INCOMING">
<orgName>Maison de Retraite Sainte Famille</orgName>
<desc>
<address>
<addrLine>2 Rue Couvents, 57950 Montigny Les Metz</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-325948" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-325948" type="direct">
<org type="institution" xml:id="struct-325948" status="VALID">
<orgName>Maison de Retraite Sainte Famille</orgName>
<desc>
<address>
<addrLine>2 Rue Couvents, 57950 Montigny Les Metz</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Vaudaine, Sarah" sort="Vaudaine, Sarah" uniqKey="Vaudaine S" first="Sarah" last="Vaudaine">Sarah Vaudaine</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-51299" status="VALID">
<orgName>Danone Research</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.danone.com/</ref>
</desc>
<listRelation>
<relation active="#struct-301296" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-301296" type="direct">
<org type="institution" xml:id="struct-301296" status="VALID">
<orgName>Groupe DANONE</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Tanguy, Jerome" sort="Tanguy, Jerome" uniqKey="Tanguy J" first="Jérôme" last="Tanguy">Jérôme Tanguy</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-51299" status="VALID">
<orgName>Danone Research</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.danone.com/</ref>
</desc>
<listRelation>
<relation active="#struct-301296" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-301296" type="direct">
<org type="institution" xml:id="struct-301296" status="VALID">
<orgName>Groupe DANONE</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bourdet Sicard, Raphaelle" sort="Bourdet Sicard, Raphaelle" uniqKey="Bourdet Sicard R" first="Raphaëlle" last="Bourdet-Sicard">Raphaëlle Bourdet-Sicard</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-51299" status="VALID">
<orgName>Danone Research</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.danone.com/</ref>
</desc>
<listRelation>
<relation active="#struct-301296" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-301296" type="direct">
<org type="institution" xml:id="struct-301296" status="VALID">
<orgName>Groupe DANONE</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Van Der Werf, Sylvie" sort="Van Der Werf, Sylvie" uniqKey="Van Der Werf S" first="Sylvie" last="Van Der Werf">Sylvie Van Der Werf</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-35815" status="OLD">
<orgName>Génétique Moléculaire des Virus Respiratoires</orgName>
<desc>
<address>
<addrLine>25-28 rue du Docteur Roux, F-75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300027" type="direct"></relation>
<relation active="#struct-300301" type="direct"></relation>
<relation name="URA3015" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300027" type="direct">
<org type="institution" xml:id="struct-300027" status="VALID">
<idno type="IdRef">027936643</idno>
<idno type="ISNI">0000 0001 2353 6535</idno>
<orgName>Institut Pasteur [Paris]</orgName>
<date type="start">1887-06-04</date>
<desc>
<address>
<addrLine>25-28, rue du docteur Roux, 75724 Paris cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.pasteur.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300301" type="direct">
<org type="institution" xml:id="struct-300301" status="OLD">
<idno type="ISNI">0000000121514068</idno>
<idno type="IdRef">027542084</idno>
<orgName>Université Paris Diderot - Paris 7</orgName>
<orgName type="acronym">UPD7</orgName>
<date type="end">2019-12-31</date>
<desc>
<address>
<addrLine>5 rue Thomas-Mann - 75205 Paris cedex 13</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-paris-diderot.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="URA3015" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:pasteur-00457701</idno>
<idno type="halId">pasteur-00457701</idno>
<idno type="halUri">https://hal-pasteur.archives-ouvertes.fr/pasteur-00457701</idno>
<idno type="url">https://hal-pasteur.archives-ouvertes.fr/pasteur-00457701</idno>
<idno type="doi">10.1016/j.vaccine.2009.06.094</idno>
<date when="2009-09-18">2009-09-18</date>
<idno type="wicri:Area/Hal/Corpus">000010</idno>
<idno type="wicri:Area/Hal/Curation">000010</idno>
<idno type="wicri:Area/Hal/Checkpoint">000285</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000285</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials.</title>
<author>
<name sortKey="Boge, Thierry" sort="Boge, Thierry" uniqKey="Boge T" first="Thierry" last="Boge">Thierry Boge</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-108489" status="INCOMING">
<orgName>Centre Hospitalier de Bourg en Bresse</orgName>
<desc>
<address>
<addrLine>Avenue Louis Jourdan, 01012 Bourg en Bresse</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-325947" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-325947" type="direct">
<org type="institution" xml:id="struct-325947" status="INCOMING">
<orgName>Centre Hospitalier de Bourg en Bresse</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Remigy, Michel" sort="Remigy, Michel" uniqKey="Remigy M" first="Michel" last="Rémigy">Michel Rémigy</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-108490" status="INCOMING">
<orgName>Maison de Retraite Sainte Famille</orgName>
<desc>
<address>
<addrLine>2 Rue Couvents, 57950 Montigny Les Metz</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-325948" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-325948" type="direct">
<org type="institution" xml:id="struct-325948" status="VALID">
<orgName>Maison de Retraite Sainte Famille</orgName>
<desc>
<address>
<addrLine>2 Rue Couvents, 57950 Montigny Les Metz</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Vaudaine, Sarah" sort="Vaudaine, Sarah" uniqKey="Vaudaine S" first="Sarah" last="Vaudaine">Sarah Vaudaine</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-51299" status="VALID">
<orgName>Danone Research</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.danone.com/</ref>
</desc>
<listRelation>
<relation active="#struct-301296" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-301296" type="direct">
<org type="institution" xml:id="struct-301296" status="VALID">
<orgName>Groupe DANONE</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Tanguy, Jerome" sort="Tanguy, Jerome" uniqKey="Tanguy J" first="Jérôme" last="Tanguy">Jérôme Tanguy</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-51299" status="VALID">
<orgName>Danone Research</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.danone.com/</ref>
</desc>
<listRelation>
<relation active="#struct-301296" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-301296" type="direct">
<org type="institution" xml:id="struct-301296" status="VALID">
<orgName>Groupe DANONE</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bourdet Sicard, Raphaelle" sort="Bourdet Sicard, Raphaelle" uniqKey="Bourdet Sicard R" first="Raphaëlle" last="Bourdet-Sicard">Raphaëlle Bourdet-Sicard</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-51299" status="VALID">
<orgName>Danone Research</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.danone.com/</ref>
</desc>
<listRelation>
<relation active="#struct-301296" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-301296" type="direct">
<org type="institution" xml:id="struct-301296" status="VALID">
<orgName>Groupe DANONE</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Van Der Werf, Sylvie" sort="Van Der Werf, Sylvie" uniqKey="Van Der Werf S" first="Sylvie" last="Van Der Werf">Sylvie Van Der Werf</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-35815" status="OLD">
<orgName>Génétique Moléculaire des Virus Respiratoires</orgName>
<desc>
<address>
<addrLine>25-28 rue du Docteur Roux, F-75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300027" type="direct"></relation>
<relation active="#struct-300301" type="direct"></relation>
<relation name="URA3015" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300027" type="direct">
<org type="institution" xml:id="struct-300027" status="VALID">
<idno type="IdRef">027936643</idno>
<idno type="ISNI">0000 0001 2353 6535</idno>
<orgName>Institut Pasteur [Paris]</orgName>
<date type="start">1887-06-04</date>
<desc>
<address>
<addrLine>25-28, rue du docteur Roux, 75724 Paris cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.pasteur.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300301" type="direct">
<org type="institution" xml:id="struct-300301" status="OLD">
<idno type="ISNI">0000000121514068</idno>
<idno type="IdRef">027542084</idno>
<orgName>Université Paris Diderot - Paris 7</orgName>
<orgName type="acronym">UPD7</orgName>
<date type="end">2019-12-31</date>
<desc>
<address>
<addrLine>5 rue Thomas-Mann - 75205 Paris cedex 13</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-paris-diderot.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="URA3015" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1016/j.vaccine.2009.06.094</idno>
<series>
<title level="j">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
<imprint>
<date type="datePub">2009-09-18</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>BACKGROUND: Influenza vaccination is recommended for the elderly in many countries, but immune responses are weaker compared to younger adults. OBJECTIVE: To investigate the impact of daily consumption of a probiotic dairy drink on the immune response to influenza vaccination in an elderly population of healthy volunteers over 70 years of age. DESIGN: Two randomised, multicentre, double-blind, controlled studies were conducted during two vaccination seasons in 2005-2006 (pilot) and 2006-2007 (confirmatory). Eighty-six and 222 elderly volunteers consumed either a fermented dairy drink, containing the probiotic strain Lactobacillus casei DN-114 001 and yoghurt ferments (Actimel, or a non-fermented control dairy product twice daily for a period of 7 weeks (pilot) or 13 weeks (confirmatory). Vaccination occurred after 4 weeks of product consumption. Geometric mean antibody titres (GMT) against the 3 viral strains composing the vaccine (H1N1, H3N2, and B) were measured at several time intervals post-vaccination by haemagglutination inhibition test. RESULTS: In the pilot study, the influenza-specific antibody titres increased after vaccination, being consistently higher in the probiotic product group compared to the control group under product consumption. Similarly, in the confirmatory study, titres against the B strain increased significantly more in the probiotic group than in the control group at 3, 6 and 9 weeks post-vaccination under product consumption (p=0.020). Significant differences in seroconversion between the groups by intended to treat analysis were still found 5 months after vaccination. Similar GMT results were observed for the H3N2 strain and H1N1 strain, confirming the results of the pilot study. CONCLUSION: These studies demonstrate that daily consumption of this particular probiotic product increased relevant specific antibody responses to influenza vaccination in individuals of over 70 years of age and may therefore provide a health benefit in this population.</p>
</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials.</title>
<author role="aut">
<persName>
<forename type="first">Thierry</forename>
<surname>Boge</surname>
</persName>
<idno type="halauthorid">468127</idno>
<affiliation ref="#struct-108489"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Michel</forename>
<surname>Rémigy</surname>
</persName>
<idno type="halauthorid">468128</idno>
<affiliation ref="#struct-108490"></affiliation>
</author>
<author role="crp">
<persName>
<forename type="first">Sarah</forename>
<surname>Vaudaine</surname>
</persName>
<email type="md5">3cb14bcce5cad6624ca459aed7f4aa85</email>
<email type="domain">danone.com</email>
<idno type="halauthorid">468129</idno>
<affiliation ref="#struct-51299"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Jérôme</forename>
<surname>Tanguy</surname>
</persName>
<idno type="halauthorid">468130</idno>
<affiliation ref="#struct-51299"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Raphaëlle</forename>
<surname>Bourdet-Sicard</surname>
</persName>
<idno type="halauthorid">468131</idno>
<affiliation ref="#struct-51299"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Sylvie</forename>
<surname>Van Der Werf</surname>
</persName>
<idno type="halauthorid">202082</idno>
<affiliation ref="#struct-35815"></affiliation>
</author>
<editor role="depositor">
<persName>
<forename>Mireille</forename>
<surname>Gau</surname>
</persName>
<email type="md5">d8e7d25ec4f9484c5e9c18bfe1543897</email>
<email type="domain">pasteur.fr</email>
</editor>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2010-02-18 11:25:49</date>
<date type="whenModified">2020-03-28 02:07:49</date>
<date type="whenReleased">2010-02-19 13:23:57</date>
<date type="whenProduced">2009-09-18</date>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="120034">
<persName>
<forename>Mireille</forename>
<surname>Gau</surname>
</persName>
<email type="md5">d8e7d25ec4f9484c5e9c18bfe1543897</email>
<email type="domain">pasteur.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">pasteur-00457701</idno>
<idno type="halUri">https://hal-pasteur.archives-ouvertes.fr/pasteur-00457701</idno>
<idno type="halBibtex">boge:pasteur-00457701</idno>
<idno type="halRefHtml">Vaccine, Elsevier, 2009, 27 (41), pp.5677-84. ⟨10.1016/j.vaccine.2009.06.094⟩</idno>
<idno type="halRef">Vaccine, Elsevier, 2009, 27 (41), pp.5677-84. ⟨10.1016/j.vaccine.2009.06.094⟩</idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="PASTEUR">Institut Pasteur</idno>
<idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
<idno type="stamp" n="RIIP_PARIS">Institut Pasteur de Paris</idno>
<idno type="stamp" n="UNIV-PARIS7" corresp="UNIV-PARIS">Université Denis Diderot - Paris VII</idno>
<idno type="stamp" n="USPC">Université Sorbonne Paris Cité</idno>
<idno type="stamp" n="UNIV-PARIS">Université de Paris</idno>
</seriesStmt>
<notesStmt>
<note type="audience" n="2">International</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials.</title>
<author role="aut">
<persName>
<forename type="first">Thierry</forename>
<surname>Boge</surname>
</persName>
<idno type="halauthorid">468127</idno>
<affiliation ref="#struct-108489"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Michel</forename>
<surname>Rémigy</surname>
</persName>
<idno type="halauthorid">468128</idno>
<affiliation ref="#struct-108490"></affiliation>
</author>
<author role="crp">
<persName>
<forename type="first">Sarah</forename>
<surname>Vaudaine</surname>
</persName>
<email type="md5">3cb14bcce5cad6624ca459aed7f4aa85</email>
<email type="domain">danone.com</email>
<idno type="halauthorid">468129</idno>
<affiliation ref="#struct-51299"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Jérôme</forename>
<surname>Tanguy</surname>
</persName>
<idno type="halauthorid">468130</idno>
<affiliation ref="#struct-51299"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Raphaëlle</forename>
<surname>Bourdet-Sicard</surname>
</persName>
<idno type="halauthorid">468131</idno>
<affiliation ref="#struct-51299"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Sylvie</forename>
<surname>Van Der Werf</surname>
</persName>
<idno type="halauthorid">202082</idno>
<affiliation ref="#struct-35815"></affiliation>
</author>
</analytic>
<monogr>
<idno type="halJournalId" status="VALID">19820</idno>
<idno type="issn">0264-410X</idno>
<idno type="eissn">0264-410X</idno>
<title level="j">Vaccine</title>
<imprint>
<publisher>Elsevier</publisher>
<biblScope unit="volume">27</biblScope>
<biblScope unit="issue">41</biblScope>
<biblScope unit="pp">5677-84</biblScope>
<date type="datePub">2009-09-18</date>
<date type="dateEpub">2009-07-16</date>
</imprint>
</monogr>
<idno type="doi">10.1016/j.vaccine.2009.06.094</idno>
<idno type="pubmed">19615959</idno>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="en">English</language>
</langUsage>
<textClass>
<classCode scheme="mesh">Aged</classCode>
<classCode scheme="mesh">Aged, 80 and over</classCode>
<classCode scheme="mesh">Influenza A Virus, H3N2 Subtype</classCode>
<classCode scheme="mesh">Influenza B virus</classCode>
<classCode scheme="mesh">Influenza Vaccines</classCode>
<classCode scheme="mesh">Lactobacillus casei</classCode>
<classCode scheme="mesh">Male</classCode>
<classCode scheme="mesh">Placebos</classCode>
<classCode scheme="mesh">Probiotics</classCode>
<classCode scheme="mesh">Antibodies, Viral</classCode>
<classCode scheme="mesh">Dairy Products</classCode>
<classCode scheme="mesh">Double-Blind Method</classCode>
<classCode scheme="mesh">Female</classCode>
<classCode scheme="mesh">Hemagglutination Inhibition Tests</classCode>
<classCode scheme="mesh">Humans</classCode>
<classCode scheme="mesh">Immunologic Factors</classCode>
<classCode scheme="mesh">Influenza A Virus, H1N1 Subtype</classCode>
<classCode scheme="halDomain" n="sdv.mp.par">Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en">
<p>BACKGROUND: Influenza vaccination is recommended for the elderly in many countries, but immune responses are weaker compared to younger adults. OBJECTIVE: To investigate the impact of daily consumption of a probiotic dairy drink on the immune response to influenza vaccination in an elderly population of healthy volunteers over 70 years of age. DESIGN: Two randomised, multicentre, double-blind, controlled studies were conducted during two vaccination seasons in 2005-2006 (pilot) and 2006-2007 (confirmatory). Eighty-six and 222 elderly volunteers consumed either a fermented dairy drink, containing the probiotic strain Lactobacillus casei DN-114 001 and yoghurt ferments (Actimel, or a non-fermented control dairy product twice daily for a period of 7 weeks (pilot) or 13 weeks (confirmatory). Vaccination occurred after 4 weeks of product consumption. Geometric mean antibody titres (GMT) against the 3 viral strains composing the vaccine (H1N1, H3N2, and B) were measured at several time intervals post-vaccination by haemagglutination inhibition test. RESULTS: In the pilot study, the influenza-specific antibody titres increased after vaccination, being consistently higher in the probiotic product group compared to the control group under product consumption. Similarly, in the confirmatory study, titres against the B strain increased significantly more in the probiotic group than in the control group at 3, 6 and 9 weeks post-vaccination under product consumption (p=0.020). Significant differences in seroconversion between the groups by intended to treat analysis were still found 5 months after vaccination. Similar GMT results were observed for the H3N2 strain and H1N1 strain, confirming the results of the pilot study. CONCLUSION: These studies demonstrate that daily consumption of this particular probiotic product increased relevant specific antibody responses to influenza vaccination in individuals of over 70 years of age and may therefore provide a health benefit in this population.</p>
</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Hal/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000285 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Checkpoint/biblio.hfd -nk 000285 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Hal
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Hal:pasteur-00457701
   |texte=   A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials.
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021